Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05338996 · ClinicalTrials.gov registry record · NA
Addressing Health Disparities in Engagement, Retention, and Utilization of PrEP Among South Florida Women of Color
A NA study of HIV Prevention and PrEP Adherence, sponsored by Florida International University.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 3
- Study locations
NCT05338996: Completed NA study of HIV Prevention and PrEP Adherence, sponsored by Florida International University.
NCT05338996 is a NA study of HIV Prevention and PrEP Adherence that has completed, run by Florida International University. The registered enrollment target is 72 participants, below the 380-participant average among 32 other HIV Prevention trials with a reported enrollment target (81% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05338996, a NA study of HIV Prevention and PrEP Adherence, has completed, sponsored by Florida International University.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 3
- Study locations
Study Summary
Women of color (WOC) in South Florida, the region with the highest HIV rates in the U.S., experience significant barriers to accessibility, uptake, and utilization of Pre-exposure prophylaxis (PrEP) for HIV prevention, despite FDA approval since 2012. The purpose of this study is to use a Community-Based Participatory Research (CBPR) approach to finalize, and pilot-test a multi-component evidence-based intervention to reduce health disparities in engagement, utilization, and retention in PrEP care, with the goal of improving HIV prevention outcomes for the target population of WOC in S. Florida, primarily African American, Latina, and Haitian women in 3 designated Ending the HIV Epidemic (EHE) counties: Miami-Dade, Broward, and Palm Beach counties.
Primary Outcome
We will measure the percentage of women who, having been invited for screening, complete the screening and enroll in the study.
Conditions Studied
Interventions
- BEHAVIORAL iENGAGE for PrEP
Study Locations (3)
Florida
- Care 4 U Community Health Center - Miami
- Care Resource, Inc. - Miami
- Monarch Health Services, Inc. - West Palm Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2023-05-31 |
| Phase | NA |
What the finished NCT05338996 record still lists
NCT05338996 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 380-participant average among 32 other HIV Prevention trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with HIV Prevention appearing as the primary indexed condition, and to 1 intervention - of which iENGAGE for PrEP is the first listed.
NCT05338996 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05338996 about?
NCT05338996 is a clinical study titled "Addressing Health Disparities in Engagement, Retention, and Utilization of PrEP Among South Florida Women of Color". Women of color (WOC) in South Florida, the region with the highest HIV rates in the U.S., experience significant barriers to accessibility, uptake, and utilization of Pre-exposure prophylaxis (PrEP) for HIV prevention, despite FDA approval since 2012. The purpose of this study is to use a Community-...
What is the current status of trial NCT05338996?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2021-10-01. Estimated completion is 2023-05-31.
What conditions does trial NCT05338996 study?
This clinical trial studies the following conditions: HIV Prevention, PrEP Adherence.
What interventions are being tested in trial NCT05338996?
The interventions under investigation include: iENGAGE for PrEP (BEHAVIORAL).
Who is sponsoring clinical trial NCT05338996?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05338996 being conducted?
This trial has 3 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05338996's enrollment target sits among peer trials
72 22nd of 32 higher than 11 of 32 other HIV Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Using PrEP, Doing It for Ourselves
RECRUITING · NA
-
Client-Centered Care Coordination for Black Men Who Have Sex With Men
RECRUITING · NA
-
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
RECRUITING · NA
-
Intervention to Enhance PrEP Persistence
RECRUITING · NA
-
WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
RECRUITING · NA
-
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI